APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Adult Preventable Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Adult Preventable Vaccines Industry Growth and Trends Forecast to 2032

Report ID 173960980126 December 2025112 pages

Choose your research edition.

Industry ResearchAdult Preventable Vaccines Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Adult Preventable Vaccines Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Adult Preventable Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adult Preventable Vaccines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Adult Preventable Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Adult Preventable Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Adult Preventable Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Adult Preventable Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adult Preventable Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Adult Preventable Vaccines include Sanofi Pasteur, Johnson & Johnson (Janssen), Pfizer Inc., GlaxoSmithKline plc (GSK), Sinovac Biotech, Sinopharm Group Co.,, Serum Institute of India Pvt., Novavax, Inc. and Moderna, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Adult Preventable Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Adult Preventable Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Adult Preventable Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Adult Preventable Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Adult Preventable Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Adult Preventable Vaccines Market by Company

Sanofi Pasteur

Johnson & Johnson (Janssen)

Pfizer Inc.

GlaxoSmithKline plc (GSK)

Sinovac Biotech

Sinopharm Group Co.,

Serum Institute of India Pvt.

Novavax, Inc.

Moderna, Inc.

Merck & Co., Inc.

Emergent BioSolutions Inc.

Daiichi Sankyo Company

CSL Limited (Seqirus)

Bharat Biotech International

AstraZeneca plc

Adult Preventable Vaccines Segment by Type

Viral Vector Vaccines

Peptide Vaccines

Inactivated Vaccines

Subunit Vaccines

Mrna Vaccines

Adult Preventable Vaccines Segment by Application

Prevent Herpes Zoster

Prevent Pneumococcal Infection

Prevent Influenza

Prevent Human Papillomavirus (Hpv)

Prevent Hepatitis B

Other

Adult Preventable Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult Preventable Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adult Preventable Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult Preventable Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Adult Preventable Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Adult Preventable Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Viral Vector Vaccines Table 2. Major Company of Peptide Vaccines Table 3. Major Company of Inactivated Vaccines Table 4. Major Company of Subunit Vaccines Table 5. Major Company of Mrna Vaccines Table 6. Global Adult Preventable Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 8. Global Adult Preventable Vaccines Sales Market Share in Volume by Type (2021-2026) Table 9. Global Adult Preventable Vaccines Sales by Type (2021-2026) & (US$ Million) Table 10. Global Adult Preventable Vaccines Sales Market Share in Value by Type (2021-2026) Table 11. Global Adult Preventable Vaccines Price by Type (2021-2026) & (US$/Unit) Table 12. Global Adult Preventable Vaccines Sales by Type (2027-2032) & (K Units) Table 13. Global Adult Preventable Vaccines Sales Market Share in Volume by Type (2027-2032) Table 14. Global Adult Preventable Vaccines Sales by Type (2027-2032) & (US$ Million) Table 15. Global Adult Preventable Vaccines Sales Market Share in Value by Type (2027-2032) Table 16. Global Adult Preventable Vaccines Price by Type (2027-2032) & (US$/Unit) Table 17. North America Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 18. North America Adult Preventable Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 20. Europe Adult Preventable Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Adult Preventable Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 24. Latin America Adult Preventable Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Adult Preventable Vaccines Sales by Type (2021-2026) & (US$ Million) Table 27. Adult Preventable Vaccines Industry Trends Table 28. Adult Preventable Vaccines Industry Drivers Table 29. Adult Preventable Vaccines Industry Opportunities and Challenges Table 30. Adult Preventable Vaccines Industry Restraints Table 31. Global Adult Preventable Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Adult Preventable Vaccines Revenue Market Share by Company (2021-2026) Table 33. Global Adult Preventable Vaccines Sales by Company (2021-2026) & (K Units) Table 34. Global Adult Preventable Vaccines Sales Share by Company (2021-2026) Table 35. Global Adult Preventable Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Adult Preventable Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Adult Preventable Vaccines Major Company Production Sites and Headquarters Table 38. Global Adult Preventable Vaccines Company, Product Type & Application Table 39. Global Adult Preventable Vaccines Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Adult Preventable Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Adult Preventable Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Adult Preventable Vaccines Sales by Region (2021-2026) & (K Units) Table 44. Global Adult Preventable Vaccines Sales Market Share in Volume by Region (2021-2026) Table 45. Global Adult Preventable Vaccines Sales by Region (2021-2026) & (US$ Million) Table 46. Global Adult Preventable Vaccines Sales Market Share in Value by Region (2021-2026) Table 47. Global Adult Preventable Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Adult Preventable Vaccines Sales by Region (2027-2032) & (K Units) Table 49. Global Adult Preventable Vaccines Sales Market Share in Volume by Region (2027-2032) Table 50. Global Adult Preventable Vaccines Sales by Region (2027-2032) & (US$ Million) Table 51. Global Adult Preventable Vaccines Sales Market Share in Value by Region (2027-2032) Table 52. Global Adult Preventable Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Adult Preventable Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 55. Global Adult Preventable Vaccines Sales Market Share in Volume by Application (2021-2026) Table 56. Global Adult Preventable Vaccines Sales by Application (2021-2026) & (US$ Million) Table 57. Global Adult Preventable Vaccines Sales Market Share in Value by Application (2021-2026) Table 58. Global Adult Preventable Vaccines Price by Application (2021-2026) & (US$/Unit) Table 59. Global Adult Preventable Vaccines Sales by Application (2027-2032) & (K Units) Table 60. Global Adult Preventable Vaccines Sales Market Share in Volume by Application (2027-2032) Table 61. Global Adult Preventable Vaccines Sales by Application (2027-2032) & (US$ Million) Table 62. Global Adult Preventable Vaccines Sales Market Share in Value by Application (2027-2032) Table 63. Global Adult Preventable Vaccines Price by Application (2027-2032) & (US$/Unit) Table 64. North America Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 65. North America Adult Preventable Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 67. Europe Adult Preventable Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Adult Preventable Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 71. Latin America Adult Preventable Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Adult Preventable Vaccines Sales by Application (2021-2026) & (US$ Million) Table 74. Sanofi Pasteur Company Information Table 75. Sanofi Pasteur Business Overview Table 76. Sanofi Pasteur Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sanofi Pasteur Adult Preventable Vaccines Product Portfolio Table 78. Sanofi Pasteur Recent Development Table 79. Johnson & Johnson (Janssen) Company Information Table 80. Johnson & Johnson (Janssen) Business Overview Table 81. Johnson & Johnson (Janssen) Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Johnson & Johnson (Janssen) Adult Preventable Vaccines Product Portfolio Table 83. Johnson & Johnson (Janssen) Recent Development Table 84. Pfizer Inc. Company Information Table 85. Pfizer Inc. Business Overview Table 86. Pfizer Inc. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Pfizer Inc. Adult Preventable Vaccines Product Portfolio Table 88. Pfizer Inc. Recent Development Table 89. GlaxoSmithKline plc (GSK) Company Information Table 90. GlaxoSmithKline plc (GSK) Business Overview Table 91. GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Product Portfolio Table 93. GlaxoSmithKline plc (GSK) Recent Development Table 94. Sinovac Biotech Company Information Table 95. Sinovac Biotech Business Overview Table 96. Sinovac Biotech Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sinovac Biotech Adult Preventable Vaccines Product Portfolio Table 98. Sinovac Biotech Recent Development Table 99. Sinopharm Group Co., Company Information Table 100. Sinopharm Group Co., Business Overview Table 101. Sinopharm Group Co., Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sinopharm Group Co., Adult Preventable Vaccines Product Portfolio Table 103. Sinopharm Group Co., Recent Development Table 104. Serum Institute of India Pvt. Company Information Table 105. Serum Institute of India Pvt. Business Overview Table 106. Serum Institute of India Pvt. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Serum Institute of India Pvt. Adult Preventable Vaccines Product Portfolio Table 108. Serum Institute of India Pvt. Recent Development Table 109. Novavax, Inc. Company Information Table 110. Novavax, Inc. Business Overview Table 111. Novavax, Inc. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Novavax, Inc. Adult Preventable Vaccines Product Portfolio Table 113. Novavax, Inc. Recent Development Table 114. Moderna, Inc. Company Information Table 115. Moderna, Inc. Business Overview Table 116. Moderna, Inc. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Moderna, Inc. Adult Preventable Vaccines Product Portfolio Table 118. Moderna, Inc. Recent Development Table 119. Merck & Co., Inc. Company Information Table 120. Merck & Co., Inc. Business Overview Table 121. Merck & Co., Inc. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Merck & Co., Inc. Adult Preventable Vaccines Product Portfolio Table 123. Merck & Co., Inc. Recent Development Table 124. Emergent BioSolutions Inc. Company Information Table 125. Emergent BioSolutions Inc. Business Overview Table 126. Emergent BioSolutions Inc. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Emergent BioSolutions Inc. Adult Preventable Vaccines Product Portfolio Table 128. Emergent BioSolutions Inc. Recent Development Table 129. Daiichi Sankyo Company Company Information Table 130. Daiichi Sankyo Company Business Overview Table 131. Daiichi Sankyo Company Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Daiichi Sankyo Company Adult Preventable Vaccines Product Portfolio Table 133. Daiichi Sankyo Company Recent Development Table 134. CSL Limited (Seqirus) Company Information Table 135. CSL Limited (Seqirus) Business Overview Table 136. CSL Limited (Seqirus) Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. CSL Limited (Seqirus) Adult Preventable Vaccines Product Portfolio Table 138. CSL Limited (Seqirus) Recent Development Table 139. Bharat Biotech International Company Information Table 140. Bharat Biotech International Business Overview Table 141. Bharat Biotech International Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Bharat Biotech International Adult Preventable Vaccines Product Portfolio Table 143. Bharat Biotech International Recent Development Table 144. AstraZeneca plc Company Information Table 145. AstraZeneca plc Business Overview Table 146. AstraZeneca plc Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. AstraZeneca plc Adult Preventable Vaccines Product Portfolio Table 148. AstraZeneca plc Recent Development Table 149. North America Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. North America Adult Preventable Vaccines Sales by Country (2021-2026) & (K Units) Table 151. North America Adult Preventable Vaccines Sales Market Share by Country (2021-2026) Table 152. North America Adult Preventable Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 153. North America Adult Preventable Vaccines Sales Market Share Forecast by Country (2027-2032) Table 154. North America Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. North America Adult Preventable Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 156. North America Adult Preventable Vaccines Market Share by Country (2021-2026) Table 157. North America Adult Preventable Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. North America Adult Preventable Vaccines Market Share Forecast by Country (2027-2032) Table 159. Europe Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Europe Adult Preventable Vaccines Sales by Country (2021-2026) & (K Units) Table 161. Europe Adult Preventable Vaccines Sales Market Share by Country (2021-2026) Table 162. Europe Adult Preventable Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 163. Europe Adult Preventable Vaccines Sales Market Share Forecast by Country (2027-2032) Table 164. Europe Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Europe Adult Preventable Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 166. Europe Adult Preventable Vaccines Market Share by Country (2021-2026) Table 167. Europe Adult Preventable Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Europe Adult Preventable Vaccines Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Adult Preventable Vaccines Sales by Country (2021-2026) & (K Units) Table 171. Asia-Pacific Adult Preventable Vaccines Sales Market Share by Country (2021-2026) Table 172. Asia-Pacific Adult Preventable Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 173. Asia-Pacific Adult Preventable Vaccines Sales Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific Adult Preventable Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 176. Asia-Pacific Adult Preventable Vaccines Market Share by Country (2021-2026) Table 177. Asia-Pacific Adult Preventable Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Asia-Pacific Adult Preventable Vaccines Market Share Forecast by Country (2027-2032) Table 179. Latin America Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 180. Latin America Adult Preventable Vaccines Sales by Country (2021-2026) & (K Units) Table 181. Latin America Adult Preventable Vaccines Sales Market Share by Country (2021-2026) Table 182. Latin America Adult Preventable Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 183. Latin America Adult Preventable Vaccines Sales Market Share Forecast by Country (2027-2032) Table 184. Latin America Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Latin America Adult Preventable Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 186. Latin America Adult Preventable Vaccines Market Share by Country (2021-2026) Table 187. Latin America Adult Preventable Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Latin America Adult Preventable Vaccines Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Adult Preventable Vaccines Sales by Country (2021-2026) & (K Units) Table 191. Middle East and Africa Adult Preventable Vaccines Sales Market Share by Country (2021-2026) Table 192. Middle East and Africa Adult Preventable Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 193. Middle East and Africa Adult Preventable Vaccines Sales Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa Adult Preventable Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 196. Middle East and Africa Adult Preventable Vaccines Market Share by Country (2021-2026) Table 197. Middle East and Africa Adult Preventable Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Middle East and Africa Adult Preventable Vaccines Market Share Forecast by Country (2027-2032) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Adult Preventable Vaccines Distributors List Table 202. Adult Preventable Vaccines Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Adult Preventable Vaccines Image Figure 2. Global Adult Preventable Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adult Preventable Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Adult Preventable Vaccines Sales (2021-2032) & (K Units) Figure 5. Viral Vector Vaccines Image Figure 6. Global Viral Vector Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Peptide Vaccines Image Figure 8. Global Peptide Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Inactivated Vaccines Image Figure 10. Global Inactivated Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 11. Subunit Vaccines Image Figure 12. Global Subunit Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 13. Mrna Vaccines Image Figure 14. Global Mrna Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Adult Preventable Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Adult Preventable Vaccines Market Share by Type 2025 VS 2032 Figure 17. North America Adult Preventable Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. North America Adult Preventable Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Europe Adult Preventable Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Europe Adult Preventable Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Adult Preventable Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Adult Preventable Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Latin America Adult Preventable Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Adult Preventable Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Adult Preventable Vaccines Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Adult Preventable Vaccines Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Adult Preventable Vaccines Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Prevent Herpes Zoster Image Figure 30. Global Prevent Herpes Zoster Sales YoY Growth (2021-2032) & (K Units) Figure 31. Prevent Pneumococcal Infection Image Figure 32. Global Prevent Pneumococcal Infection Sales YoY Growth (2021-2032) & (K Units) Figure 33. Prevent Influenza Image Figure 34. Global Prevent Influenza Sales YoY Growth (2021-2032) & (K Units) Figure 35. Prevent Human Papillomavirus (Hpv) Image Figure 36. Global Prevent Human Papillomavirus (Hpv) Sales YoY Growth (2021-2032) & (K Units) Figure 37. Prevent Hepatitis B Image Figure 38. Global Prevent Hepatitis B Sales YoY Growth (2021-2032) & (K Units) Figure 39. Other Image Figure 40. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 41. Global Adult Preventable Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Adult Preventable Vaccines Market Share by Application 2025 VS 2032 Figure 43. North America Adult Preventable Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. North America Adult Preventable Vaccines Sales Market Share in Value by Application in 2025 Figure 45. Europe Adult Preventable Vaccines Sales Market Share in Volume by Application in 2025 Figure 46. Europe Adult Preventable Vaccines Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Adult Preventable Vaccines Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Adult Preventable Vaccines Sales Market Share in Value by Application in 2025 Figure 49. Latin America Adult Preventable Vaccines Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Adult Preventable Vaccines Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Adult Preventable Vaccines Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Adult Preventable Vaccines Sales Market Share in Value by Application in 2025 Figure 53. North America Adult Preventable Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. North America Adult Preventable Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Adult Preventable Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Adult Preventable Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Adult Preventable Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Europe Adult Preventable Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Adult Preventable Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Adult Preventable Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Adult Preventable Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Asia-Pacific Adult Preventable Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Adult Preventable Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Adult Preventable Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Adult Preventable Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Latin America Adult Preventable Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Adult Preventable Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Adult Preventable Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Adult Preventable Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 70. Middle East and Africa Adult Preventable Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Adult Preventable Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Adult Preventable Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Adult Preventable Vaccines Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Adult Preventable Vaccines Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Vector Vaccines
  • Peptide Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Mrna Vaccines
Applications
  • Prevent Herpes Zoster
  • Prevent Pneumococcal Infection
  • Prevent Influenza
  • Prevent Human Papillomavirus (Hpv)
  • Prevent Hepatitis B
  • Other
Companies covered
  • Sanofi Pasteur
  • Johnson & Johnson (Janssen)
  • Pfizer Inc.
  • GlaxoSmithKline plc (GSK)
  • Sinovac Biotech
  • Sinopharm Group Co.,
  • Serum Institute of India Pvt.
  • Novavax, Inc.
  • Moderna, Inc.
  • Merck & Co., Inc.
  • Emergent BioSolutions Inc.
  • Daiichi Sankyo Company
  • CSL Limited (Seqirus)
  • Bharat Biotech International
  • AstraZeneca plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Adult Preventable Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Adult Preventable Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Adult Preventable Vaccines Market by Type
  6. 1.3.1 Viral Vector Vaccines
  7. 1.3.2 Peptide Vaccines
  8. 1.3.3 Inactivated Vaccines
  9. 1.3.4 Subunit Vaccines
  10. 1.3.5 Mrna Vaccines
  11. 1.4 Global Adult Preventable Vaccines Market Size by Type
  12. 1.4.1 Global Adult Preventable Vaccines Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Adult Preventable Vaccines Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Adult Preventable Vaccines Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Adult Preventable Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Adult Preventable Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Adult Preventable Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Adult Preventable Vaccines Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Adult Preventable Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Adult Preventable Vaccines Industry Trends
  2. 2.2 Adult Preventable Vaccines Industry Drivers
  3. 2.3 Adult Preventable Vaccines Industry Opportunities and Challenges
  4. 2.4 Adult Preventable Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Adult Preventable Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Adult Preventable Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Adult Preventable Vaccines Price (2021-2026)
  4. 3.4 Global Adult Preventable Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Adult Preventable Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Adult Preventable Vaccines Company, Product Type & Application
  7. 3.7 Global Adult Preventable Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Adult Preventable Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Adult Preventable Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Adult Preventable Vaccines Tier 1, Tier 2, and Tier 3
4 Adult Preventable Vaccines Regional Status and Outlook
  1. 4.1 Global Adult Preventable Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Adult Preventable Vaccines Historic Market Size by Region
  3. 4.2.1 Global Adult Preventable Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Adult Preventable Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Adult Preventable Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Adult Preventable Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Adult Preventable Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Adult Preventable Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Adult Preventable Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Adult Preventable Vaccines by Application
  1. 5.1 Adult Preventable Vaccines Market by Application
  2. 5.1.1 Prevent Herpes Zoster
  3. 5.1.2 Prevent Pneumococcal Infection
  4. 5.1.3 Prevent Influenza
  5. 5.1.4 Prevent Human Papillomavirus (Hpv)
  6. 5.1.5 Prevent Hepatitis B
  7. 5.1.6 Other
  8. 5.2 Global Adult Preventable Vaccines Market Size by Application
  9. 5.2.1 Global Adult Preventable Vaccines Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Adult Preventable Vaccines Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Adult Preventable Vaccines Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Adult Preventable Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Adult Preventable Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Adult Preventable Vaccines Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Adult Preventable Vaccines Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Adult Preventable Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi Pasteur
  2. 6.1.1 Sanofi Pasteur Company Information
  3. 6.1.2 Sanofi Pasteur Business Overview
  4. 6.1.3 Sanofi Pasteur Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Pasteur Adult Preventable Vaccines Product Portfolio
  6. 6.1.5 Sanofi Pasteur Recent Developments
  7. 6.2 Johnson & Johnson (Janssen)
  8. 6.2.1 Johnson & Johnson (Janssen) Company Information
  9. 6.2.2 Johnson & Johnson (Janssen) Business Overview
  10. 6.2.3 Johnson & Johnson (Janssen) Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson (Janssen) Adult Preventable Vaccines Product Portfolio
  12. 6.2.5 Johnson & Johnson (Janssen) Recent Developments
  13. 6.3 Pfizer Inc.
  14. 6.3.1 Pfizer Inc. Company Information
  15. 6.3.2 Pfizer Inc. Business Overview
  16. 6.3.3 Pfizer Inc. Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Inc. Adult Preventable Vaccines Product Portfolio
  18. 6.3.5 Pfizer Inc. Recent Developments
  19. 6.4 GlaxoSmithKline plc (GSK)
  20. 6.4.1 GlaxoSmithKline plc (GSK) Company Information
  21. 6.4.2 GlaxoSmithKline plc (GSK) Business Overview
  22. 6.4.3 GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Product Portfolio
  24. 6.4.5 GlaxoSmithKline plc (GSK) Recent Developments
  25. 6.5 Sinovac Biotech
  26. 6.5.1 Sinovac Biotech Company Information
  27. 6.5.2 Sinovac Biotech Business Overview
  28. 6.5.3 Sinovac Biotech Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sinovac Biotech Adult Preventable Vaccines Product Portfolio
  30. 6.5.5 Sinovac Biotech Recent Developments
  31. 6.6 Sinopharm Group Co.,
  32. 6.6.1 Sinopharm Group Co., Company Information
  33. 6.6.2 Sinopharm Group Co., Business Overview
  34. 6.6.3 Sinopharm Group Co., Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sinopharm Group Co., Adult Preventable Vaccines Product Portfolio
  36. 6.6.5 Sinopharm Group Co., Recent Developments
  37. 6.7 Serum Institute of India Pvt.
  38. 6.7.1 Serum Institute of India Pvt. Company Information
  39. 6.7.2 Serum Institute of India Pvt. Business Overview
  40. 6.7.3 Serum Institute of India Pvt. Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Serum Institute of India Pvt. Adult Preventable Vaccines Product Portfolio
  42. 6.7.5 Serum Institute of India Pvt. Recent Developments
  43. 6.8 Novavax, Inc.
  44. 6.8.1 Novavax, Inc. Company Information
  45. 6.8.2 Novavax, Inc. Business Overview
  46. 6.8.3 Novavax, Inc. Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novavax, Inc. Adult Preventable Vaccines Product Portfolio
  48. 6.8.5 Novavax, Inc. Recent Developments
  49. 6.9 Moderna, Inc.
  50. 6.9.1 Moderna, Inc. Company Information
  51. 6.9.2 Moderna, Inc. Business Overview
  52. 6.9.3 Moderna, Inc. Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Moderna, Inc. Adult Preventable Vaccines Product Portfolio
  54. 6.9.5 Moderna, Inc. Recent Developments
  55. 6.10 Merck & Co., Inc.
  56. 6.10.1 Merck & Co., Inc. Company Information
  57. 6.10.2 Merck & Co., Inc. Business Overview
  58. 6.10.3 Merck & Co., Inc. Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck & Co., Inc. Adult Preventable Vaccines Product Portfolio
  60. 6.10.5 Merck & Co., Inc. Recent Developments
  61. 6.11 Emergent BioSolutions Inc.
  62. 6.11.1 Emergent BioSolutions Inc. Company Information
  63. 6.11.2 Emergent BioSolutions Inc. Business Overview
  64. 6.11.3 Emergent BioSolutions Inc. Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Emergent BioSolutions Inc. Adult Preventable Vaccines Product Portfolio
  66. 6.11.5 Emergent BioSolutions Inc. Recent Developments
  67. 6.12 Daiichi Sankyo Company
  68. 6.12.1 Daiichi Sankyo Company Company Information
  69. 6.12.2 Daiichi Sankyo Company Business Overview
  70. 6.12.3 Daiichi Sankyo Company Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Daiichi Sankyo Company Adult Preventable Vaccines Product Portfolio
  72. 6.12.5 Daiichi Sankyo Company Recent Developments
  73. 6.13 CSL Limited (Seqirus)
  74. 6.13.1 CSL Limited (Seqirus) Company Information
  75. 6.13.2 CSL Limited (Seqirus) Business Overview
  76. 6.13.3 CSL Limited (Seqirus) Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 CSL Limited (Seqirus) Adult Preventable Vaccines Product Portfolio
  78. 6.13.5 CSL Limited (Seqirus) Recent Developments
  79. 6.14 Bharat Biotech International
  80. 6.14.1 Bharat Biotech International Company Information
  81. 6.14.2 Bharat Biotech International Business Overview
  82. 6.14.3 Bharat Biotech International Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bharat Biotech International Adult Preventable Vaccines Product Portfolio
  84. 6.14.5 Bharat Biotech International Recent Developments
  85. 6.15 AstraZeneca plc
  86. 6.15.1 AstraZeneca plc Company Information
  87. 6.15.2 AstraZeneca plc Business Overview
  88. 6.15.3 AstraZeneca plc Adult Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 AstraZeneca plc Adult Preventable Vaccines Product Portfolio
  90. 6.15.5 AstraZeneca plc Recent Developments
7 North America by Country
  1. 7.1 North America Adult Preventable Vaccines Sales by Country
  2. 7.1.1 North America Adult Preventable Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Adult Preventable Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Adult Preventable Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Adult Preventable Vaccines Market Size by Country
  6. 7.2.1 North America Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Adult Preventable Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Adult Preventable Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Adult Preventable Vaccines Sales by Country
  2. 8.1.1 Europe Adult Preventable Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Adult Preventable Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Adult Preventable Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Adult Preventable Vaccines Market Size by Country
  6. 8.2.1 Europe Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Adult Preventable Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Adult Preventable Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Adult Preventable Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Adult Preventable Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Adult Preventable Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Adult Preventable Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Adult Preventable Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Adult Preventable Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Adult Preventable Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Adult Preventable Vaccines Sales by Country
  2. 10.1.1 South America Adult Preventable Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Adult Preventable Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Adult Preventable Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Adult Preventable Vaccines Market Size by Country
  6. 10.2.1 South America Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Adult Preventable Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Adult Preventable Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Adult Preventable Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Adult Preventable Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Adult Preventable Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Adult Preventable Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Adult Preventable Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Adult Preventable Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Adult Preventable Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Adult Preventable Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Adult Preventable Vaccines Value Chain Analysis
  2. 12.1.1 Adult Preventable Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Adult Preventable Vaccines Production Mode & Process
  7. 12.2 Adult Preventable Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Adult Preventable Vaccines Distributors
  10. 12.2.3 Adult Preventable Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst